Recent advancements in applications of ionic liquids in synthetic construction of heterocyclic scaffolds: A spotlight
TM Dhameliya, PR Nagar, KA Bhakhar… - Journal of Molecular …, 2022 - Elsevier
Heterocycles constitute the integral part of the most of United States food and drug
administration (USFDA) approved drugs. Over the past decade, ionic liquids have emerged …
administration (USFDA) approved drugs. Over the past decade, ionic liquids have emerged …
Treatment of atrazine-containing wastewater by algae-bacteria consortia: Signal transmission and metabolic mechanism
F Xu, M Liu, S Zhang, T Chen, J Sun, W Wu, Z Zhao… - Chemosphere, 2023 - Elsevier
Atrazine is a toxic endocrine disruptor. Biological treatment methods are considered to be
effective. In the present study, a modified version of the algae-bacteria consortia (ABC) was …
effective. In the present study, a modified version of the algae-bacteria consortia (ABC) was …
Recent advances in meglumine catalyzed organic synthesis: A comprehensive review
DR Bhandari, UJ Khengar, RH Vekariya… - Synthetic …, 2024 - Taylor & Francis
Meglumine, an amino sugar alcohol compound, has recently emerged as a promising
catalyst in various organic transformations due to its unique properties. This review provides …
catalyst in various organic transformations due to its unique properties. This review provides …
Distinguishing drug/non-drug-like small molecules in drug discovery using deep belief network
SA Hooshmand, SA Jamalkandi, SM Alavi… - Molecular Diversity, 2021 - Springer
The advent of computational methods for efficient prediction of the druglikeness of small
molecules and their ever-burgeoning applications in the fields of medicinal chemistry and …
molecules and their ever-burgeoning applications in the fields of medicinal chemistry and …
An efficient and expeditious synthesis of 1, 2, 4-triazolidine-3-thiones using meglumine as a reusable catalyst in water
A simple, convenient, and eco-friendly procedure has been developed using meglumine (15
mol%) as a green catalyst for the synthesis of 1, 2, 4-triazolidine-3-thiones under one-pot …
mol%) as a green catalyst for the synthesis of 1, 2, 4-triazolidine-3-thiones under one-pot …
Nano molar level chromogenic and fluorogenic sensing of heavy metal ions using multi-responsive novel Schiff base as a dual mode chemosensor
A Schiff base centered chemosensor namely (2E, NE)-N-(2, 4-dihydroxybenzylidene)-2-
(quinolin-2-ylmethylene) hydrazinecarbothioamide ie SB has been synthesized and further …
(quinolin-2-ylmethylene) hydrazinecarbothioamide ie SB has been synthesized and further …
Synthesis, characterization of 1, 2, 4-triazolidine-3-thione tethered beta-aryl butanoic acid and butanoate derivatives as potent antimicrobial and antioxidant agents …
NU Hebbar, PS Hebbar, PP Rathode… - Journal of Molecular …, 2023 - Elsevier
As a tactic for the drug discovery and development framework to tackle resistance to
antibiotics, the target triazolidine-3-thione substituted butanoic acid and butanoate …
antibiotics, the target triazolidine-3-thione substituted butanoic acid and butanoate …
[PDF][PDF] 低剂量莠去津暴露饮用水诱导小鼠肝损伤模型的建立及验证
朱玉, 苏莹实, 刘溪, 何宝国, 秦嫘 - 中国比较医学杂志, 2024 - zgbjyx.cnjournals.com
目的建立长期饮喂低剂量莠去津诱发小鼠肝损伤模型, 并评价莠去津引起的肝毒性作用.
方法C57BL/6-N 雄性小鼠随机分为对照组以及1. 5 mg/L 和150 mg/L 剂量(ATR-L, ATR-H) 组 …
方法C57BL/6-N 雄性小鼠随机分为对照组以及1. 5 mg/L 和150 mg/L 剂量(ATR-L, ATR-H) 组 …
Synthesis of fused Azo-linked 1, 2, 4-Triazole-3-Thione derivatives using Ag2S/RHA-MCM-41 nanocomposite
Z Jafarian, M Nikpassand… - … Journal of Nano …, 2022 - ijnd.tonekabon.iau.ir
Magnetic nanoparticles have received much attention in synthesizing organic compounds
due to their unique properties such as high contact surface, recyclability, and easy …
due to their unique properties such as high contact surface, recyclability, and easy …
Design, synthesis, and in vitro evaluation of novel 1, 3, 4-oxadiazolecarbamothioate derivatives of Rivastigmine as selective inhibitors of BuChE
A Fallah, F Mohanazadeh, M Safavi - Medicinal Chemistry Research, 2020 - Springer
Rivastigmine has been prescribed for the therapy of Alzheimer's disease (AD) symptoms.
This drug is classified in the carbamate derivative group that has dual activity against …
This drug is classified in the carbamate derivative group that has dual activity against …